Innovassynth Technologies (India) Ltd

Innovassynth Technologies Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Innovassynth Technologies (India) Ltd

₹ 73.4 1.79%
13 Feb - close price
innovassynthinvestments.in BSE: 533315
About

Incorporated in 2008, Innovassynth Investments Ltd is a holding and investment company

Key Points

Business Associate:[1][2][3]
Company invested in Innovassynth Technologies (India) Limited (~31.79%), which is its Associate from 12 February 2022. ITIL is R&D and technology-based Organization engaged in developing, scaling up and manufacturing of specialty chemicals and pharmaceutical Intermediates. Key focus business areas are customs synthesis, contract research & manufacturing of specialty chemicals, toll manufacture of chemicals and similar businesses. It also supplies protected nucleosides and modified phosphonamidites used for clinical, diagnostic and therapeutic oligonucleotides applications. On 12th February 2022, Managing Director of Innovassynth Technologies Ltd was appointed as Managing Director of company resulting into establishment of significant influence over ITIL. Company has not diversified its investment in other entities except ITIL

Website BSE
  • Market Cap ₹ 554 Cr.
  • Current Price ₹ 73.4
  • High / Low ₹ 140 / 59.9
  • Stock P/E
  • Book Value ₹ 5.66
  • Dividend Yield 0.00 %
  • ROCE -0.99 %
  • ROE -2.13 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Promoter holding has increased by 42.2% over last quarter.

Cons

  • Stock is trading at 13.0 times its book value
  • Company has low interest coverage ratio.
  • Company has a low return on equity of -2.04% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Financial Services Financial Services Finance Investment Company

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 49.91 0.00 0.00 17.28 21.97
0.09 0.08 0.10 0.08 0.08 0.09 0.09 0.12 38.50 0.09 0.11 28.38 26.05
Operating Profit -0.09 -0.08 -0.10 -0.08 -0.08 -0.09 -0.09 -0.12 11.41 -0.09 -0.11 -11.10 -4.08
OPM % 22.86% -64.24% -18.57%
0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.28 1.16 -0.01 0.00 0.09 -0.39
Interest 0.08 0.08 0.08 0.09 0.09 0.12 0.09 0.10 1.79 0.11 0.11 1.76 1.89
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.95 0.00 0.00 1.99 1.97
Profit before tax -0.17 -0.16 -0.18 -0.17 -0.17 -0.21 -0.18 -0.50 8.83 -0.21 -0.22 -14.76 -8.33
Tax % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -4.08% 0.00% 0.00% -3.25% -6.36%
-0.17 -0.16 -0.18 -0.17 -0.17 -0.21 -0.18 -0.50 9.19 -0.21 -0.22 -14.28 -7.80
EPS in Rs -0.07 -0.07 -0.07 -0.07 -0.07 -0.09 -0.07 -0.18 3.28 -0.08 -0.08 -5.10 -1.03
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
0 0 0 0 0 0 0 0 0 0 0 0 39
0 0 0 0 0 0 0 0 0 0 0 0 55
Operating Profit -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -15
OPM % 22% -39%
0 0 0 0 0 0 0 0 0 0 0 -0 -0
Interest 0 0 0 0 0 0 0 0 0 0 0 0 4
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0 4
Profit before tax -0 -0 -0 -0 -0 -1 -1 -1 -1 -1 -1 -1 -24
Tax % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
-0 -0 -0 -0 -0 -1 -1 -1 -1 -1 -1 -1 -23
EPS in Rs -0.07 -0.10 -0.13 -0.14 -0.16 -0.22 -0.23 -0.21 -0.27 -0.27 -0.29 -0.41 -6.29
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -21%
Compounded Profit Growth
10 Years: %
5 Years: -13%
3 Years: -10%
TTM: -353%
Stock Price CAGR
10 Years: 24%
5 Years: 65%
3 Years: 56%
1 Year: -5%
Return on Equity
10 Years: -2%
5 Years: -2%
3 Years: -2%
Last Year: -2%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 24 24 24 24 24 24 24 24 24 24 24 28 28
Reserves -1 -1 -1 -2 -2 -4 -4 -4 11 10 9 15 15
0 0 1 1 1 2 2 2 3 3 4 4 5
0 0 0 0 0 0 0 1 1 1 2 2 2
Total Liabilities 24 24 24 24 24 23 23 23 39 39 39 50 50
0 0 0 0 0 0 0 0 0 0 0 0 0
CWIP 0 0 0 0 0 0 0 0 0 0 0 0 0
Investments 24 24 24 24 24 23 23 23 39 39 39 50 50
0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 24 24 24 24 24 23 23 23 39 39 39 50 50

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
-0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -1
0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 1 0 0 0 0 0 1
Net Cash Flow 0 -0 -0 0 0 0 -0 -0 0 0 -0 0

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days
Inventory Days
Days Payable
Cash Conversion Cycle
Working Capital Days
ROCE % -1% -1% -1% -1% -1% -2% -2% -1% -1% -1% -1% -1%

Shareholding Pattern

Numbers in percentages

Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
36.26% 36.26% 36.26% 36.26% 36.26% 36.26% 31.46% 31.46% 31.46% 31.46% 31.46% 73.70%
0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 1.39%
3.70% 3.70% 3.70% 3.70% 3.70% 3.70% 3.21% 3.93% 3.89% 3.89% 3.89% 1.46%
60.02% 60.02% 60.03% 60.03% 60.02% 60.03% 65.31% 64.59% 64.64% 64.64% 64.63% 23.46%
No. of Shareholders 27,66827,52527,30227,13827,19426,99126,88227,30827,15727,11727,08626,957

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls

  • Feb 2026
    Transcript
    AI Summary
    PPT